Analyst firms · Truist Securities · AMED

Truist Securities AMED price target and rating history

Amedisys Inc (AMED) · Health Care

Truist Securities rates Amedisys Inc (AMED) Hold with a $97 price target, as of its latest action on Jun 7, 2023. It has published 3 rating actions on AMED since October 2021, including 0 upgrades and 1 downgrade.

Current rating
Hold
Price target
$97
Median target, all firms
Too few
Actions on AMED
3

Truist Securities price target on AMED

$200$149$9720222023202420252026
Truist Securities price target on AMED, each point a stated target, October 2021 to June 2023.

Every Truist Securities rating on AMED

Questions about Truist Securities and AMED

What is Truist Securities's price target for AMED?
Truist Securities's latest stated price target for Amedisys Inc (AMED) is $97, from its action on Jun 7, 2023.
What is Truist Securities's rating on AMED?
Truist Securities rates AMED Hold, a neutral rating, as of Jun 7, 2023.
When did Truist Securities last change its view on AMED?
On Jun 7, 2023, Truist Securities downgrades to Hold from Buy, price target $97.

More AMED rating histories

All Truist Securities ratingsAMED news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.